Wednesday, October 19, 2016

Icatibant




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01EB19

CAS registry number (Chemical Abstracts Service)

0130308-48-4

Chemical Formula

C59-H89-N19-O13-S

Molecular Weight

1304

Therapeutic Categories

Treatment of hereditary angioedema

Bradykinin receptor B2 antagonist

Chemical Names

(R)-arginyl-(S)-arginyl-(S)-prolyl-(2S,4R)-(4-hydroxyprolyl)glycyl-(S)-[3-(2-thienyl)alanyl]-(S)-seryl-(R)-[(1,2,3,4-tetrahydro-3-isochinolyl)carbonyl]-(2S,3aS,7aS)-[(hexahydro-2-indolin-3-yl)carbonyl]-(S)-arginin (IUPAC)

(R)-Arginyl-(S)-arginyl-(S)-prolyl-(2S,4R)-(4-hydroxyprolyl)glycyl-(S)-[3-(2-thienyl)alanyl]-(S)-seryl-(R)-[(1,2,3,4-tetrahydro-3-isoquinolyl)carbonyl]-(2S,3aS,7aS)-[(hexahydro-2-indolinyl)carbonyl]-(S)-arginine (WHO)

D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2α,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-L-arginine

L-arginine, D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2α,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl- (CAS)

Foreign Names

  • Icatibantum (Latin)
  • Icatibant (German)
  • Icatibant (French)
  • Icatibanto (Spanish)

Generic Names

  • HOE 140 (IS)
  • Hoec (IS)
  • Hoechst 140 (IS)
  • JE-049 (IS: Jerini)
  • Icatibant Acetate (OS: USAN)

Brand Names

  • Firazyr
    Jerini, Greece; Jerini, Luxembourg; Drac, Switzerland; Jerini, Austria; Jerini, Germany; Jerini, Spain; Jerini, Finland; Jerini, United Kingdom; Jerini, Sweden; Shire, France

International Drug Name Search

Glossary

CASChemical Abstracts Service
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment